Trump Fast-Tracks Psychedelics

President Trump has signed an executive order allocating $50 million to increase access to psychedelic drugs like psilocybin and ibogaine for treating mental health conditions, including PTSD, depression, and anxiety. Joined by figures like RFK Jr., Joe Rogan, and Marcus Luttrell, the President directed the FDA to fast-track the review and reclassification of these substances, which are currently listed as Schedule I. The initiative aims to address the national mental health crisis, specifically highlighting successful trials among veterans and active military personnel.